Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$42.56 - $59.82 $114,784 - $161,334
-2,697 Reduced 35.79%
4,838 $273,000
Q4 2023

Feb 13, 2024

SELL
$32.18 - $46.57 $134,383 - $194,476
-4,176 Reduced 35.66%
7,535 $338,000
Q2 2023

Aug 11, 2023

SELL
$31.86 - $67.26 $448,397 - $946,617
-14,074 Reduced 54.58%
11,711 $507,000
Q1 2023

May 15, 2023

SELL
$45.44 - $74.26 $127,277 - $208,002
-2,801 Reduced 9.8%
25,785 $1.69 Million
Q4 2022

Feb 14, 2023

BUY
$41.39 - $81.0 $1.18 Million - $2.32 Million
28,586 New
28,586 $0

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Capital Group Investment Management Pte. Ltd. Portfolio

Follow Capital Group Investment Management Pte. Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Group Investment Management Pte. Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Capital Group Investment Management Pte. Ltd. with notifications on news.